iSOFT collaborates with Intel and Motion Computing on launch of Mobile Clinical Assistant

iSOFTFollowing months of development and collaboration, iSOFT has announced its intention to support its customers in their adoption of the Mobile Clinical Assistant (MCA). The platform, announced earlier by Intel Corporation and Motion Computing, will allow clinicians to spend more time with patients, help improve patient safety and reduce medication administration errors. Motion Computing's C5 is the first product based on Intel's platform and has earned support from clinicians and nurses participating in pilot studies conducted around the world.

In the UK trial at Salford Royal NHS Foundation Trust, phlebotomists and nurses used iSOFT's i.Clinical Manager (i.CM) on MCA devices. The project at Salford Royal was primarily to understand precisely how the MCA would be used in practice by clinical staff when it is integrated with actual medical and business processes.

Fifteen MCAs loaded with iSOFT's i.CM were used in a trial at Salford Royal. The ability to view and record clinical details at the point of care was found to improve the quality of information and efficiency of clinicians. Access to information in real-time proved particularly beneficial to phlebotomists as it prevented blood samples being taken unnecessarily and the need for duplicate tests. Salford Royal is an existing user of iSOFT's i.CM clinical software application as well as other iSOFT applications for patient administration, accident and emergency, and laboratory information systems.

"As a leading EMR provider, iSOFT is a natural choice for MCA trial collaboration," said Louis Burns, vice president and general manager, Intel's Digital Health Group. "We have enjoyed working closely with iSOFT, Motion, the NHS and the nurses at Salford Royal to develop a technology solution that truly serves the needs of healthcare professionals in clinical settings."

"Historically, one of the reasons EMR implementations have been only moderately successful is that independent vendors of hardware, software and infrastructure did not collaborate early enough in the solution design lifecycle," said Nigel Owens, Motion general manager of EMEA. "That's why iSOFT's work here is important. Its work with Motion and Intel will continue to help improve clinician experiences with the Motion C5 MCA."

Bill Henry, iSOFT's chief operating officer, said: "MCA is a major advance in mobile healthcare computing and finally puts computer technology into care environments safely. Having real-time clinical information to support decisions at the point of care while also minimising the risk of infection, is a huge benefit to clinical staff and patients alike. To improve the quality of healthcare and staff workflow, it is vital to have accurate and up-to-date information at the point of decision, whether on a ward or in a surgical department.

"Our collaboration with Intel and Motion, in the only clinician usability and field trial within the NHS using the Motion C5 MCA, is a testament to our standing as a world-class provider of clinical applications such as i.CM."

Henry added: "This technology offers significant opportunities for iSOFT and its customers and we will continue to work with Intel and Motion in helping to develop this set of products. We remain committed to supporting our customers in the delivery of better healthcare through the combination of our leading software and technology from partners such as Motion and Intel."

iSOFT has a long-standing commitment to mobile technology. The company was selected as Microsoft's exclusive European software partner for the launch of its tablet PC in 2002.

Related news articles:

iSOFT is Europe's largest healthcare software applications company and also has a strong presence and experience in the Asia Pacific region. Its core strategic application, LORENZO, is at the forefront of the technology revolution taking place in healthcare globally. iSOFT products are used to manage patient information in more than 8,000 organisations in 27 countries. With annual revenues of £180 million, the company has offices in 12 countries and more than 3,000 employees, over 1,400 of whom are engaged in software development and design. Further information: http://www.isoftplc.com.

Most Popular Now

AI Catches One-Third of Interval Breast …

An AI algorithm for breast cancer screening has potential to enhance the performance of digital breast tomosynthesis (DBT), reducing interval cancers by up to one-third, according to a study published...

Great plan: Now We need to Get Real abou…

The government's big plan for the 10 Year Health Plan for the NHS laid out a big role for delivery. However, the Highland Marketing advisory board felt the missing implementation...

Researchers Create 'Virtual Scienti…

There may be a new artificial intelligence-driven tool to turbocharge scientific discovery: virtual labs. Modeled after a well-established Stanford School of Medicine research group, the virtual lab is complete with an...

From WebMD to AI Chatbots: How Innovatio…

A new research article published in the Journal of Participatory Medicine unveils how successive waves of digital technology innovation have empowered patients, fostering a more collaborative and responsive health care...

New AI Tool Accelerates mRNA-Based Treat…

A new artificial intelligence (AI) model can improve the process of drug and vaccine discovery by predicting how efficiently specific mRNA sequences will produce proteins, both generally and in various...

AI also Assesses Dutch Mammograms Better…

AI is detecting tumors more often and earlier in the Dutch breast cancer screening program. Those tumors can then be treated at an earlier stage. This has been demonstrated by...

RSNA AI Challenge Models can Independent…

Algorithms submitted for an AI Challenge hosted by the Radiological Society of North America (RSNA) have shown excellent performance for detecting breast cancers on mammography images, increasing screening sensitivity while...

AI could Help Emergency Rooms Predict Ad…

Artificial intelligence (AI) can help emergency department (ED) teams better anticipate which patients will need hospital admission, hours earlier than is currently possible, according to a multi-hospital study by the...

Head-to-Head Against AI, Pharmacy Studen…

Students pursuing a Doctor of Pharmacy degree routinely take - and pass - rigorous exams to prove competency in several areas. Can ChatGPT accurately answer the same questions? A new...

NHS Active 10 Walking Tracker Users are …

Users of the NHS Active 10 app, designed to encourage people to become more active, immediately increased their amount of brisk and non-brisk walking upon using the app, according to...

New AI Tool Illuminates "Dark Side…

Proteins sustain life as we know it, serving many important structural and functional roles throughout the body. But these large molecules have cast a long shadow over a smaller subclass...

Deep Learning-Based Model Enables Fast a…

Stroke is the second leading cause of death globally. Ischemic stroke, strongly linked to atherosclerotic plaques, requires accurate plaque and vessel wall segmentation and quantification for definitive diagnosis. However, conventional...